MOLECULAR PARTNERS AG -ADR Share Price Today: Live Updates & Key Insights
MOLECULAR PARTNERS AG -ADR share price today is $4.585, up -2.24%. The stock opened at $4.26 against the previous close of $4.6899, with an intraday high of $4.26 and low of $4.26.
MOLECULAR PARTNERS AG -ADR Share Price Chart
MOLECULAR PARTNERS AG -ADR
MOLECULAR PARTNERS AG -ADR Share Price Performance
MOLECULAR PARTNERS AG -ADR Institutional Holdings
MOLECULAR PARTNERS AG -ADR Market Status
MOLECULAR PARTNERS AG -ADR Fundamentals
Market Cap 171.48 M
PB Ratio 1.6923
PE Ratio 0.0
Enterprise Value 57.51 M
Total Assets 102.11 M
Volume 2720
MOLECULAR PARTNERS AG -ADR Company Financials
About MOLECULAR PARTNERS AG -ADR & investment objective
Company Information Molecular Partners AG, a clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland. Its product pipeline comprises MP0317, which is in Phase 2 clinical trial for the treatment of advanced solid tumors; MP053, novel tetra-specific T cell-engaging DARPin, which is phase 1 clinical trial for the treatment of acute myeloid leukemia; and MP0712, a 212Pb Radio-DARPin therapy (RDT) candidate targeting the tumor-associated protein delta-like ligand 3 (DLL3) which is in Phase 1 clinical trial to treat SCLC and neuroendocrine tumors. It also researches for Switch-DARPin T cell engager to treat CD3 x costim x; and MP0726, a Radio-DARPin Therapy to treat ovarian cancer and other MSLNexpressing cancers. In addition, the company develops MP0621, a Switch-DARPin candidate targeting CD16a, c-KIT, and CD47 as conditioning for hematopoietic stem cell transplantation; and Radio-DARPin Therapy (RDT) platform, a delivery system for effective and selective delivery of radioactive payloads to solid tumors. It has collaboration agreement with Orano Med SAS to develop novel Radio-DARPin therapeutics and an additional six targeted alpha therapeutics candidates and Eckert & Ziegler SE to develop Radio-DARPin therapeutics. Molecular Partners AG was incorporated in 2004 and is headquartered in Schlieren, Switzerland.
Organisation Biotechnology
Employees 134
Industry Biotechnology
CEO Dr. Patrick Amstutz Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
MOLECULAR PARTNERS AG -ADR FAQs
What is the share price of MOLECULAR PARTNERS AG -ADR today?
The current share price of MOLECULAR PARTNERS AG -ADR is $4.585.
Can I buy MOLECULAR PARTNERS AG -ADR shares in India?
Yes, Indian investors can buy MOLECULAR PARTNERS AG -ADR shares by opening an international trading and demat account with Motilal Oswal.
How to buy MOLECULAR PARTNERS AG -ADR shares in India?
You can easily invest in MOLECULAR PARTNERS AG -ADR shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy MOLECULAR PARTNERS AG -ADR shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of MOLECULAR PARTNERS AG -ADR.
Can I buy fractional shares of MOLECULAR PARTNERS AG -ADR?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of MOLECULAR PARTNERS AG -ADR?
MOLECULAR PARTNERS AG -ADR has a market cap of $171.48 M.
In which sector does MOLECULAR PARTNERS AG -ADR belong?
MOLECULAR PARTNERS AG -ADR operates in the Biotechnology sector.
What documents are required to invest in MOLECULAR PARTNERS AG -ADR stocks?
To invest, you typically need:
What is the PE and PB ratio of MOLECULAR PARTNERS AG -ADR?
The PE ratio of MOLECULAR PARTNERS AG -ADR is N/A and the PB ratio is 1.69.